menu
    • menu

    Company profile for Rome Therapeutics

    NEW Drugs in Dev: 1
    Evonik

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    ROME Therapeutics is developing novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome – vast stretches of uncharted genetic material that have long been dismissed as “junk DNA.” With several drug targets identified and multiple discovery programs underway, ROME is moving rapidly to leverage this new frontier in biology. To lead this exploration, ROME has assembled a team of world-cl...
    ROME Therapeutics is developing novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome – vast stretches of uncharted genetic material that have long been dismissed as “junk DNA.” With several drug targets identified and multiple discovery programs underway, ROME is moving rapidly to leverage this new frontier in biology. To lead this exploration, ROME has assembled a team of world-class leaders across fields including oncology, immunology, virology and machine learning.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Rome TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    700 Main Street North, Cambridge, MA 02139, US
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://rometx.com/home/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/rome-therapeutics/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Pretzel Emerges As Winner From Rise And Fall Of Rome
    Pretzel Emerges As Winner From Rise And Fall Of Rome

    13 Jan 2026

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/pretzel-winner-rise-and-fall-rome-therapeutics

    FIERCE BIOTECH
    13 Jan 2026
    Share Share
    Rome Nears End of Road with Planned Layoffs, Strategic Review
    Rome Nears End of Road with Planned Layoffs, Strategic Review

    23 Sep 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/big-pharma-backed-rome-therapeutics-nears-end-road-planned-layoffs-and-strategic-review

    FIERCE BIOTECH
    23 Sep 2025
    Share Share
    ROME Therapeutics Appoints Heike Keilhack, Ph.D., as Chief Scientific Officer
    ROME Therapeutics Appoints Heike Keilhack, Ph.D., as Chief Scientific Officer

    04 Jan 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240104820217/en

    BUSINESSWIRE
    04 Jan 2024
    Share Share
    Rome’s ‘dark genome’ drug reduces autoimmune markers in mice
    Rome’s ‘dark genome’ drug reduces autoimmune markers in mice

    17 Nov 2023

    // Helen Floersh FIERCE BIOTECH

    https://www.fiercebiotech.com/research/rome-therapeutics-dark-genome-drug-shows-early-efficacy-against-autoimmune-disease-mice

    Helen Floersh FIERCE BIOTECH
    17 Nov 2023
    Share Share
    ROME Therapeutics Closes Oversubscribed $72 Million Series B Extension
    ROME Therapeutics Closes Oversubscribed $72 Million Series B Extension

    12 Sep 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230912740459/en

    BUSINESSWIRE
    12 Sep 2023
    Share Share
    Rome advances dark genome drug after completing $72M Series B extension
    Rome advances dark genome drug after completing $72M Series B extension

    12 Sep 2023

    // Ayisha Sharma ENDPTS

    https://endpts.com/rome-therapeutics-advances-dark-genome-drug-after-72m-series-b-extension-backed-by-big-pharma/

    Ayisha Sharma ENDPTS
    12 Sep 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search